)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Orchid Pharma (ORCHPHARMA) investor relations material
Orchid Pharma Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 25/26 earnings summary11 Nov, 2025
Executive summary
Q2 FY26 sales were INR 194 crore, down 13% year-on-year, with H1 FY26 sales down 22% compared to H1 FY25.
EBITDA for Q2 FY26 was INR 6 crore, down from INR 14 crore in Q1 FY26 and 61% lower year-on-year, with margin falling to 8% from 17%.
Net profit after tax (PAT) fell 92% year-on-year in Q2 FY26, but consolidated net profit was ₹1,371.12 lakhs, up from a Q1 FY26 loss.
Board approved unaudited standalone and consolidated results for Q2 and H1 FY26, with a modified auditor's conclusion.
Completed acquisition of global rights to emmetazobactam and Exblifeb, consolidating global antibiotic presence.
Financial highlights
Q2 FY26 sales: INR 194 crore, down 13% YoY, up 13% QoQ; H1 FY26 sales down 22% YoY.
Gross margin declined to 32% from 43% in Q1 FY26 and to 38% from 39% YoY.
EBITDA: INR 6 crore (down from INR 14 crore in Q1 FY26); EBITDA margin dropped to 8% from 17% YoY.
PAT margin fell to 1% in Q2 FY26 from 11% in Q2 FY25.
Consolidated net profit for Q2 FY26 was ₹1,371.12 lakhs, with EPS of ₹2.94.
Outlook and guidance
No signs of antibiotics market recovery expected in FY26; focus on licensing Exblifeb and progressing key projects.
AMS division expected to break even by next year, with sales team potentially breaking even by Q4 FY26.
Royalty and sales data from emmetazobactam acquisition to be reflected from the December quarter onwards.
Awaiting NCLT approval for Dhanuka Labs amalgamation, with next hearing in November 2025.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Orchid Pharma earnings date
Q3 25/2611 Feb, 2026
Next Orchid Pharma earnings date
Q3 25/2611 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Orchid Pharma Limited is a pharmaceutical company engaged in the manufacturing and marketing of active pharmaceutical ingredients (APIs) and finished dosage formulations. The company focuses on therapeutic areas such as anti-infectives, including beta-lactam antibiotics, and also operates in segments like cardiovascular and central nervous system treatments. Its operations include research and development, chemical synthesis, and formulation development for both domestic and international markets. The company is headquartered in Chennai, India, and its shares are listed on the BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage